[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BRPI0407116A - Partìcula revestida baseada em princìpio ativo, composição farmacêutica ou cosmética, e, método para produção de partìcula revestida com princìpio ativo - Google Patents

Partìcula revestida baseada em princìpio ativo, composição farmacêutica ou cosmética, e, método para produção de partìcula revestida com princìpio ativo

Info

Publication number
BRPI0407116A
BRPI0407116A BR0407116-6A BRPI0407116A BRPI0407116A BR PI0407116 A BRPI0407116 A BR PI0407116A BR PI0407116 A BRPI0407116 A BR PI0407116A BR PI0407116 A BRPI0407116 A BR PI0407116A
Authority
BR
Brazil
Prior art keywords
particle
coated particle
active principle
active
pharmaceutical
Prior art date
Application number
BR0407116-6A
Other languages
English (en)
Inventor
Philippe Chenevrier
Dominique Marechal
Original Assignee
Ethypharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm Sa filed Critical Ethypharm Sa
Publication of BRPI0407116A publication Critical patent/BRPI0407116A/pt
Publication of BRPI0407116B1 publication Critical patent/BRPI0407116B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/003—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic followed by coating of the granules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated
    • Y10T428/2998—Coated including synthetic resin or polymer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

"PARTìCULA REVESTIDA BASEADA EM PRINCìPIO ATIVO, COMPOSIçãO FARMACêUTICA OU COSMéTICA, E, MéTODO PARA PRODUçãO DE PARTìCULA REVESTIDA COM PRINCìPIO ATIVO". Partícula revestida baseada em princípio ativo na qual ambos, o núcleo e o revestimento, contêm princípio ativo, na qual o núcleo contém um primeiro princípio ativo enquanto o revestimento contém um segundo princípio ativo, o qual é de natureza diferente.
BRPI0407116-6A 2003-02-05 2004-01-21 Partícula revestida baseada em princípio ativo, composição farmacêutica ou cosmética, e, método para produção de partícula revestida baseada em princípio ativo BRPI0407116B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR0301308A FR2850576B1 (fr) 2003-02-05 2003-02-05 Composition comprenant un melange de principes actifs, et procede de preparation
FR0301308 2003-02-05
US44719803P 2003-02-13 2003-02-13
US60/447,198 2003-02-13
PCT/EP2004/050035 WO2004069135A2 (en) 2003-02-05 2004-01-21 Composition comprising a mixture of active principles, and method of preparation

Publications (2)

Publication Number Publication Date
BRPI0407116A true BRPI0407116A (pt) 2006-01-10
BRPI0407116B1 BRPI0407116B1 (pt) 2018-04-03

Family

ID=32852330

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0407116-6A BRPI0407116B1 (pt) 2003-02-05 2004-01-21 Partícula revestida baseada em princípio ativo, composição farmacêutica ou cosmética, e, método para produção de partícula revestida baseada em princípio ativo

Country Status (18)

Country Link
US (2) US7846460B2 (pt)
EP (1) EP1589954B1 (pt)
JP (1) JP4791348B2 (pt)
KR (1) KR20050096963A (pt)
CN (1) CN1747723B (pt)
AU (1) AU2004210438B2 (pt)
BR (1) BRPI0407116B1 (pt)
CA (1) CA2514446C (pt)
EA (1) EA010972B1 (pt)
ES (1) ES2590807T3 (pt)
FR (1) FR2850576B1 (pt)
IL (1) IL169880A (pt)
IS (1) IS7998A (pt)
MX (1) MXPA05008161A (pt)
NO (1) NO341294B1 (pt)
NZ (1) NZ541886A (pt)
PL (1) PL223347B1 (pt)
WO (1) WO2004069135A2 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI483944B (zh) * 2004-03-30 2015-05-11 Euro Celtique Sa 含有小於２５ｐｐｍ１４-羥可待因酮之羥可酮鹽酸鹽組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝
US8163114B2 (en) * 2004-04-07 2012-04-24 New Jersey Institute Of Technology Netshape manufacturing processes and compositions
KR101158162B1 (ko) 2005-08-02 2012-06-19 솔-겔 테크놀로지스 리미티드 수 불용성 성분을 금속 산화물로 피복시키는 방법
FR2897267A1 (fr) * 2006-02-16 2007-08-17 Flamel Technologies Sa Formes pharmaceutiques multimicroparticulaires pour administration per os
AU2007280470B2 (en) 2006-08-04 2013-03-14 Ethypharm Granule and orally disintegrating tablet comprising oxycodone
KR20090057399A (ko) * 2006-09-26 2009-06-05 노파르티스 아게 Ｓ１ｐ 조정제를 포함하는 제약 조성물
WO2008089774A1 (fr) * 2007-01-22 2008-07-31 Crd Saidal Formulation d'un comprime orodispersible a base de paracetamol enrobe
KR20090121291A (ko) 2007-02-01 2009-11-25 솔-겔 테크놀로지스 리미티드 산화금속 코팅을 포함한 입자의 제조방법 및 산화금속 코팅을 포함한 입자
EA200970724A1 (ru) 2007-02-01 2010-02-26 Сол-Джел Текнолоджиз Лтд. Композиции для местного применения, содержащие пероксид и ретиноид
TWI455732B (zh) * 2007-12-27 2014-10-11 Taiho Pharmaceutical Co Ltd 經口粉粒狀抗腫瘤劑
TW201041608A (en) * 2009-05-01 2010-12-01 Eurand Inc Orally disintegrating tablet compositions comprising combinations of high and low-dose drugs
CN102526124B (zh) * 2011-01-31 2013-11-20 成都科尔医药技术有限公司 一种中药粉体及其制备方法
EP3170492B1 (en) * 2012-03-02 2020-07-08 Rhodes Pharmaceuticals L.P. Tamper resistant immediate release formulations
JP6320297B2 (ja) * 2012-09-13 2018-05-09 ライオン株式会社 発泡性口腔用組成物、発泡性口腔用固形製剤及び発泡性口腔用製品
WO2014059512A1 (en) * 2012-10-15 2014-04-24 Isa Odidi Oral drug delivery formulations
KR101484608B1 (ko) * 2012-11-26 2015-01-22 한국과학기술연구원 Pva와 알지네이트 기반 코어-쉘 구조의 복합담체 및 그 제조방법
US9687465B2 (en) 2012-11-27 2017-06-27 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
EP2950923B1 (en) 2013-02-01 2022-03-09 W.R. Grace & CO. - CONN. Porous silica gel as a carrier for liquid technologies
CA3042642A1 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9707184B2 (en) 2014-07-17 2017-07-18 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
CA2964628A1 (en) 2014-10-20 2016-04-28 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
CN111990641A (zh) * 2020-05-06 2020-11-27 焦作百仑斯生物科技有限公司 一种解酒护肝片及施工方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000044404A (ja) * 1998-07-27 2000-02-15 Otsuka Chem Co Ltd 農業用混合粒剤
CA2259727A1 (en) * 1999-01-18 2000-07-18 Bernard Charles Sherman A two-layer pharmaceutical tablet comprising an nsaid and misoprostol
US6296874B1 (en) * 2000-05-01 2001-10-02 Aeropharm Technology Incorporated Core formulation comprising troglitazone and abiguanide
US6451342B2 (en) * 2000-05-01 2002-09-17 Aeropharm Technology Incorporated Core formulation comprised of troglitazone and a biguanide
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
FR2816507B1 (fr) * 2000-11-16 2003-02-28 Ethypharm Lab Prod Ethiques Microgranules a base de principe actif, procede de fabrication et compositons pharmaceutiques integrant lesdits microgranules
SI1575566T1 (sl) * 2002-12-26 2012-08-31 Pozen Inc Veäśplastna dozirna oblika vsebujoäśa naproksen in triptane

Also Published As

Publication number Publication date
CA2514446C (en) 2012-04-10
US20110081389A1 (en) 2011-04-07
HK1087015A1 (zh) 2006-10-06
KR20050096963A (ko) 2005-10-06
JP4791348B2 (ja) 2011-10-12
FR2850576B1 (fr) 2007-03-23
PL223347B1 (pl) 2016-10-31
NO20053799L (no) 2005-08-11
IL169880A (en) 2013-10-31
IL169880A0 (en) 2007-07-04
AU2004210438A1 (en) 2004-08-19
PL376465A1 (en) 2005-12-27
EA200501250A1 (ru) 2006-02-24
ES2590807T3 (es) 2016-11-23
US20060134422A1 (en) 2006-06-22
JP2006516597A (ja) 2006-07-06
AU2004210438B2 (en) 2007-08-16
NZ541886A (en) 2008-12-24
EP1589954A2 (en) 2005-11-02
CN1747723A (zh) 2006-03-15
BRPI0407116B1 (pt) 2018-04-03
WO2004069135A3 (en) 2004-10-28
EP1589954B1 (en) 2016-08-31
CA2514446A1 (en) 2004-08-19
MXPA05008161A (es) 2005-10-05
NO341294B1 (no) 2017-10-02
US7846460B2 (en) 2010-12-07
FR2850576A1 (fr) 2004-08-06
CN1747723B (zh) 2010-05-12
EA010972B1 (ru) 2008-12-30
IS7998A (is) 2005-08-25
WO2004069135A2 (en) 2004-08-19

Similar Documents

Publication Publication Date Title
BRPI0407116A (pt) Partìcula revestida baseada em princìpio ativo, composição farmacêutica ou cosmética, e, método para produção de partìcula revestida com princìpio ativo
BR0111020B1 (pt) composição de revestimento fotoativável, processo para produção de uma camada de revestimento, e, uso de uma composição de revestimento.
RS50091B (sr) Upotreba retigabina u lečenju neuropatskog bola
WO2002074274A3 (en) Oral care kits and compositions
AU2003221225A8 (en) Caco3/si2o " nh2o nanocomposite particles, si2o " nh2o nanomaterial and method of producing the same
DE60122636D1 (de) Beschichtungszusammensetzungen, deren Herstellung und Verwendung, beschichtete Gegenstände
BR0014087A (pt) Composições com pérolas de caroteno - xantofila estáveis e métodos de uso
ES2177022T3 (es) Un itraconazol que exhibe una solubilidad mejorada, un metodo para preparar el mismo y una composicion farmaceutica para administracion oral que comprende el mismo.
BR9904039A (pt) Preparação de partìculas farmaceuticamente ativas
MXPA05007934A (es) Articulo absorbente desechable que comprende una capa recolectora hidrofilica durable.
BR0116725A (pt) Composição de espuma, fita adesiva, artigo, e, métodos de fabricação de uma composição de espuma, de fabricação de uma fita, de determinação da compatibilidade de um veìculo predeterminado e as nanopartìculas modificadas na superfìcie e de formação de espuma em uma composição
BR9707499A (pt) Partículas de dióxido de titânico anatásio processo para preparaç o das partículas utilizaç o das partículas e composiç o cosmética anti-uv
BRPI0416114A (pt) materiais compósitos compreendendo nanopartìculas carregadas com metal
AU2002253126A1 (en) Use of creatine, creatinine and/or derivatives thereof
BR9809465A (pt) Composições de cuidados com a pele e método para melhorar a aparência da pele
DE60105665D1 (de) Beschichtungszusammensetzung, Beschichtungsverfahren und beschichtete Gegenstände
NO20032211D0 (no) Pulverbelegg med lav glans
BR9710247A (pt) Partículas de dióxido de titánio anatásio processo para sua fabricação utilização das partículas composição cosmética anti-uv e composição de revestimento anti-uv
BR0214404A (pt) Bolsa solúvel em água, processo para produção da mesma e uso de um pó com absorção de óleo especìfica igual ou superior a 0,4 ml/m2
WO2000074662A3 (en) Arthritis treatment
DE60234346D1 (de) Kosmetischer rohstoff mit verbesserten eigenschaften und verfahren zu seiner herstellung
DE60323474D1 (de) Orale pharmazeutische formulierung in form einer wässrigen suspension von mikrokapseln zur modifizierten freisetzung von amoxicillin
BR0114379A (pt) Derivados de c-ciclohexilmetilamina substituìdos
BR0107485A (pt) Composição cosmética, e, método de conferir às unhas humanas um revestimento cosmético de flexibilidade melhorada, durável e/ou de resistência à transferência
ATE345160T1 (de) Topisches produkt mit visuellem indikator

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8, 13 E 25 DA LPI

B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 16A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2550 DE 19-11-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.